ALK inhibitor response in melanomas expressing EML4-ALK fusions and alternate ALK isoforms

Oncogenic ALK fusions occur in several types of cancer and can be effectively treated with ALK inhibitors; however, ALK fusions and treatment response have not been characterized in malignant melanomas. Recently, a novel isoform of ALK (ALK(ATI)) was reported in 11% of melanomas but the response of...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Cancer Ther
Main Authors: Couts, Kasey L., Bemis, Judson, Turner, Jacqueline A., Bagby, Stacey M., Murphy, Danielle, Christiansen, Jason, Hintzsche, Jennifer D., Le, Anh, Pitts, Todd M., Wells, Keith, Applegate, Allison, Amato, Carol, Multani, Pratik, Chow-Maneval, Edna, Tentler, John J., Shellman, Yiqun G., Rioth, Matthew J., Tan, Aik-Choon, Gonzalez, Rene, Medina, Theresa, Doebele, Robert C., Robinson, William A.
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5752582/
https://ncbi.nlm.nih.gov/pubmed/29054983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-0472
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker